While the association between the increased symptomatology observed in Rome IV IBS population and higher BMI remains unclear, studies have hypothesized that obesity, with its associated low-grade chronic inflammation, can lead to increased serum levels of inflammatory molecules such as complement components and C-reactive protein, further exacerbating IBS symptoms [8]. This evidence concerns the gene CRP and irritable bowel syndrome.